148 related articles for article (PubMed ID: 37873766)
21. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
Bartley J; Baird DT
BJOG; 2002 Nov; 109(11):1290-4. PubMed ID: 12452468
[TBL] [Abstract][Full Text] [Related]
22. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.
Ashok PW; Templeton A
Br J Obstet Gynaecol; 1999 Jul; 106(7):706-10. PubMed ID: 10428528
[TBL] [Abstract][Full Text] [Related]
23. Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol.
Jannet D; Aflak N; Abankwa A; Carbonne B; Marpeau L; Milliez J
Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(2):159-63. PubMed ID: 9119097
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
25. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
[TBL] [Abstract][Full Text] [Related]
26. Update on second-trimester surgical abortion.
Shaw KA; Lerma K
Curr Opin Obstet Gynecol; 2016 Dec; 28(6):510-516. PubMed ID: 27684047
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.
Ngai SW; Tang OS; Ho PC
Hum Reprod; 2000 Oct; 15(10):2205-8. PubMed ID: 11006200
[TBL] [Abstract][Full Text] [Related]
28. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review.
Goyal V
Obstet Gynecol; 2009 May; 113(5):1117-1123. PubMed ID: 19384128
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.
Henkel A; Lerma K; Blumenthal PD; Shaw KA
Contraception; 2020 Nov; 102(5):327-331. PubMed ID: 32592800
[TBL] [Abstract][Full Text] [Related]
32. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
[TBL] [Abstract][Full Text] [Related]
33. Surgical versus medical methods for second trimester induced abortion.
Lohr PA; Hayes JL; Gemzell-Danielsson K
Cochrane Database Syst Rev; 2008 Jan; (1):CD006714. PubMed ID: 18254113
[TBL] [Abstract][Full Text] [Related]
34. Clinical application of low-dose misoprostol in the induced labor of 16 to 28 weeks pathological pregnancies (a STROBE-compliant article).
Yang Y; Wang Y; Du X; Duan J; Huang YM
Medicine (Baltimore); 2019 Oct; 98(40):e17396. PubMed ID: 31577749
[TBL] [Abstract][Full Text] [Related]
35. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
[TBL] [Abstract][Full Text] [Related]
36. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
[TBL] [Abstract][Full Text] [Related]
37. Cervical preparation for first trimester surgical abortion.
Kapp N; Lohr PA; Ngo TD; Hayes JL
Cochrane Database Syst Rev; 2010 Feb; (2):CD007207. PubMed ID: 20166091
[TBL] [Abstract][Full Text] [Related]
38. Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section.
Cayrac M; Faillie JL; Flandrin A; Boulot P
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):145-9. PubMed ID: 21511389
[TBL] [Abstract][Full Text] [Related]
39. Complication rates of dilation and evacuation and labor induction in second-trimester abortion for fetal indications: A retrospective cohort study.
Jacques L; Heinlein M; Ralph J; Pan A; Nugent M; Kaljo K; Farez R
Contraception; 2020 Aug; 102(2):83-86. PubMed ID: 32360665
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
